{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,16]],"date-time":"2022-04-16T20:46:56Z","timestamp":1650142016515},"reference-count":48,"publisher":"Bentham Science Publishers Ltd.","issue":"4","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CVP"],"published-print":{"date-parts":[[2019,6,11]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>We hypothesized that perioperative HbA1c influenced the pattern and outcomes\nof Lower Extremity Amputation (LEA).<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>A retrospective analysis was conducted for all patients who underwent LEA between 2000\nand 2013. Patients were categorized into 5 groups according to their perioperative HbA1c values [Group\n1 (&lt;6.5%), Group 2 (6.5-7.4%), Group 3 (7.5-8.4%), Group 4 (8.5-9.4%) and Group 5 (\u22659.5%)]. We\nidentified 848 patients with LEA; perioperative HbA1c levels were available in 547 cases (Group 1:\n18.8%, Group 2: 17.7%, Group 3: 15.0%, Group 4: 13.5% and Group 5: 34.9%). Major amputation was\nperformed in 35%, 32%, 22%, 10.8% and 13.6%, respectively.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>The overall mortality was 36.5%; of that one quarter occurred during the index hospitalization.\nMortality was higher in Group 1 (57.4%) compared with Groups 2-5 (46.9%, 38.3%, 36.1% and 31.2%,\nrespectively, p=0.001). Cox regression analysis showed that poor glycemic control (Group 4 and 5) had\nlower risk of mortality post-LEA [hazard ratio 0.57 (95% CI 0.35-0.93) and hazard ratio 0.46 (95% CI\n0.31-0.69)]; this mortality risk persisted even after adjustment for age and sex but was statistically insignificant.\nThe rate of LEA was greater among poor glycemic control patients; however, the mortality\nwas higher among patients with tight control.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>The effects of HbA1c on the immediate and long-term LEA outcomes and its therapeutic\nimplications need further investigation.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1570161116666180123112529","type":"journal-article","created":{"date-parts":[[2018,1,23]],"date-time":"2018-01-23T06:49:54Z","timestamp":1516690194000},"page":"354-364","update-policy":"http:\/\/dx.doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Does Perioperative Hemoglobin A1c Level Affect the Incidence, Pattern and Mortality of Lower Extremity Amputation?"],"prefix":"10.2174","volume":"17","author":[{"given":"Hassan","family":"Al-Thani","sequence":"first","affiliation":[{"name":"Department of Surgery, Vascular and Trauma Surgery, Hamad General Hospital, Doha, Qatar"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moamena","family":"El-Matbouly","sequence":"additional","affiliation":[{"name":"Department of Surgery, Hamad General Hospital, Doha, Qatar"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Al-Sulaiti","sequence":"additional","affiliation":[{"name":"Department of Surgery, Hamad General Hospital, Doha, Qatar"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noora","family":"Al-Thani","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Hamad General Hospital, Doha, Qatar"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Asim","sequence":"additional","affiliation":[{"name":"Vascular and Trauma Surgery, Clinical Research, Hamad General Hospital, Doha, Qatar"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayman","family":"El-Menyar","sequence":"additional","affiliation":[{"name":"Vascular and Trauma Surgery, Clinical Research, Hamad General Hospital, Doha, Qatar"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1001\/jama.293.2.217","volume":"293","author":"Singh N.","year":"2005","unstructured":"Singh N, Armstrong DG, Lipsky BA.  Preventing foot ulcers in patients with diabetes.","journal-title":"JAMA"},{"key":"ref=2","first-page":"187","volume":"1","author":"Thewjitcharoen Y.","year":"2014","unstructured":"Thewjitcharoen Y, Krittiyawong S, Porramatikul S.  Outcomes of hospitalized diabetic foot patients in a multi-disciplinary team setting: Thailand\u2019s experience.","journal-title":"J Clin Transl Endocrinol"},{"key":"ref=3","doi-asserted-by":"crossref","first-page":"277","DOI":"10.12968\/jowc.2005.14.6.26792","volume":"14","author":"Rai N.K.","year":"2005","unstructured":"Rai NK.  Suryabhan, Ansari M, Kumar M, Shukla VK, Tripathi K. Effect of glycaemic control on apoptosis in diabetic wounds.","journal-title":"J Wound Care"},{"key":"ref=4","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/1056-8727(95)00088-7","volume":"10","author":"van Houtum W.H.","year":"1996","unstructured":"van Houtum WH, Lavery LA, Harkless LB.  The impact of diabetes-related lower-extremity amputations in The Netherlands.","journal-title":"J Diabetes Complications"},{"key":"ref=5","first-page":"875","volume":"95","author":"Dillingham T.R.","year":"2002","unstructured":"Dillingham TR, Pezzin LE, MacKenzie EJ.  Limb amputation and limb deficiency: Epidemiology and recent trends in the United States.","journal-title":"South Med J"},{"key":"ref=6","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.2337\/dc12-2625","volume":"36","author":"","year":"2013","unstructured":".  American Diabetes Association.","journal-title":"Diabetes Care"},{"key":"ref=7","first-page":"3","volume":"17","author":"van Dieren S.","year":"2010","unstructured":"van Dieren S, Beulens JW, van der Schouw YT, Grobbee DE, Neal B.  The global burden of diabetes and its complications: An emerging pandemic.","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"ref=8","doi-asserted-by":"crossref","first-page":"477","DOI":"10.2147\/DMSO.S39093","volume":"6","author":"Kowall B.","year":"2013","unstructured":"Kowall B, Rathmann W.  HbA1c for diagnosis of type 2 diabetes. Is there an optimal cut point to assess high risk of diabetes complications, and how well does the 6.5% cutoff perform?","journal-title":"Diabetes Metab Syndr Obes"},{"key":"ref=9","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/bmj.321.7258.405","volume":"321","author":"Stratton I.M.","year":"2000","unstructured":"Stratton IM, Adler AI, Neil HA.  Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study.","journal-title":"BMJ"},{"key":"ref=10","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1007\/s00125-006-0431-0","volume":"49","author":"Davis W.A.","year":"2006","unstructured":"Davis WA, Norman PE, Bruce DG, Davis TM.  Predictors, consequences and costs of diabetes-related lower extremity amputation complicating type 2 diabetes: The Fremantle diabetes study.","journal-title":"Diabetologia"},{"key":"ref=11","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1056\/NEJMicm066227","volume":"358","author":"Patel A.","year":"2008","unstructured":"Patel A, MacMahon S, Chalmers J.  Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.","journal-title":"N Engl J Med"},{"key":"ref=12","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1478-7954-12-18","volume":"12","author":"Ali F.M.","year":"2014","unstructured":"Ali FM, Nikoloski Z, Reka H, Gjebrea O, Mossialos E.  The diabetes-obesity-hypertension nexus in Qatar: Evidence from the world health survey.","journal-title":"Popul Health Metr"},{"key":"ref=13","first-page":"417","volume":"10","author":"Swaminathan A.","year":"2014","unstructured":"Swaminathan A, Vemulapalli S, Patel MR, Jones WS.  Lower extremity amputation in peripheral artery disease: Improving patient outcomes.","journal-title":"Vasc Health Risk Manag"},{"key":"ref=14","unstructured":"International Diabetes Federation, \"I IDF Diabetes Atlas 6th ed, Diabetes Estimates, Diabetes Prevalence (%), 2035 Available at. http:\/\/www.idf.org\/atlasmap\/atlasmap) [Accessed on April 06, 2014]."},{"key":"ref=15","unstructured":"International Diabetes Foundation (IDF). Diabetes Atlas. 8th ed. (updated). 2017. Available at: http:\/\/www.diabetesatlas.org\/ resources\/2017-atlas.html"},{"key":"ref=16","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1007\/s00125-009-1638-7","volume":"53","author":"Adler A.","year":"2010","unstructured":"Adler A, Erqou S, Lima T, Robinson A.  Association between glycated haemoglobin and the risk of lower extremity amputation in patients with diabetes mellitus review and meta-analysis.","journal-title":"Diabetologia"},{"key":"ref=17","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","volume":"352","author":"","year":"1998","unstructured":".   UK Prospective Diabetes Study (UKPDS) Group.Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33).","journal-title":"Lancet"},{"key":"ref=18","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1177\/1534734615593190","volume":"14","author":"Zhou Z.","year":"2015","unstructured":"Zhou Z, Liu Y, Chen H.  HbA1c and lower extremity amputation risk in patients with diabetes: A meta-analysis.","journal-title":"Int J Low Extrem Wounds"},{"key":"ref=19","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1210\/jc.2016-3717","volume":"102","author":"Hsu C.Y.","year":"2017","unstructured":"Hsu CY, Chen YT, Su YW, Chang CC, Huang PH, Lin SJ.  Statin therapy reduces future risk of lower-limb amputation in patients with diabetes and peripheral artery disease.","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=20","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1016\/j.jvs.2017.05.115","volume":"66","author":"Stavroulakis K.","year":"2017","unstructured":"Stavroulakis K, Borowski M, Torsello G.  Association between statin therapy and amputation-free survival in patients with critical limb ischemia in the CRITISCH registry.","journal-title":"J Vasc Surg"},{"key":"ref=21","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.jacc.2013.09.073","volume":"63","author":"Westin G.G.","year":"2014","unstructured":"Westin GG, Armstrong EJ, Bang H.  Association between statin medications and mortality, major adverse cardiovascular event, and amputation-free survival in patients with critical limb ischemia.","journal-title":"J Am Coll Cardiol"},{"key":"ref=22","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1093\/eurheartj\/ehu080","volume":"35","author":"Kumbhani D.J.","year":"2014","unstructured":"Kumbhani DJ, Steg PG, Cannon CP.  Statin therapy and long-term adverse limb outcomes in patients with peripheral artery disease: Insights from the REACH registry.","journal-title":"Eur Heart J"},{"key":"ref=23","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.jvs.2013.03.050","volume":"58","author":"Chung J.","year":"2013","unstructured":"Chung J, Timaran DA, Modrall JG.  Optimal medical therapy predicts amputation-free survival in chronic critical limb ischemia.","journal-title":"J Vasc Surg"},{"key":"ref=24","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1016\/j.jvs.2013.06.069","volume":"58","author":"Sohn M.W.","year":"2013","unstructured":"Sohn MW, Meadows JL, Oh EH.  Statin use and lower extremity amputation risk in nonelderly diabetic patients.","journal-title":"J Vasc Surg"},{"key":"ref=25","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jvs.2017.01.048","volume":"66","author":"DeCarlo C.","year":"2017","unstructured":"DeCarlo C, Scher L, Shariff S.  Statin use and other factors associated with mortality after major lower extremity amputation.","journal-title":"J Vasc Surg"},{"key":"ref=26","doi-asserted-by":"crossref","first-page":"607","DOI":"10.2337\/diacare.19.6.607","volume":"19","author":"Lehto S.","year":"1996","unstructured":"Lehto S, R\u00f6nnemaa T, Py\u00f6r\u00e4l\u00e4 K, Laakso M.  Risk factors predicting lower extremity amputations in patients with NIDDM.","journal-title":"Diabetes Care"},{"key":"ref=27","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/(SICI)1096-9136(199809)15:9<765::AID-DIA663>3.0.CO;2-1","volume":"15","author":"","year":"1998","unstructured":".  Coppini DV1,Young PJ, Weng C, Macleod AF, S\u00f6nksen PH. Outcome on diabetic foot complications in relation to clinical examination and quantitative sensory testing: A case-control study.","journal-title":"Diabet Med"},{"key":"ref=28","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1745-7599.2001.tb00026.x","volume":"13","author":"Watts S.A.","year":"2001","unstructured":"Watts SA, Daly B, Anthony M, McDonald P, Khoury A, Dahar W.  The effect of age, gender, risk level and glycosylated hemoglobin in predicting foot amputation in HMO patients with diabetes.","journal-title":"J Am Acad Nurse Pract"},{"key":"ref=29","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1053\/meta.2002.30021","volume":"51","author":"Olson J.C.","year":"2002","unstructured":"Olson JC, Erbey JR, Forrest KY, Williams K, Becker DJ, Orchard TJ.  Glycemia (or, in women, estimated glucose disposal rate) predict lower extremity arterial disease events in type 1 diabetes.","journal-title":"Metabolism"},{"key":"ref=30","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.diabres.2011.03.014","volume":"93","author":"Li X.","year":"2011","unstructured":"Li X, Xiao T, Wang Y.  Incidence, risk factors for amputation among patients with diabetic foot ulcer in a Chinese tertiary hospital.","journal-title":"Diabetes Res Clin Pract"},{"key":"ref=31","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1590\/S1020-49892012000900004","volume":"32","author":"Lacle A.","year":"2012","unstructured":"Lacle A, Valero-Juan LF.  Diabetes-related lower-extremity amputation incidence and risk factors: A prospective seven-year study in Costa Rica.","journal-title":"Rev Panam Salud Publica"},{"key":"ref=32","first-page":"1686","volume":"92","author":"Fei Y.F.","year":"2012","unstructured":"Fei YF, Wang C, Chen DW.  Incidence and risk factors of amputation among inpatients with diabetic foot.","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"ref=33","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.foot.2011.09.003","volume":"22","author":"Zubair M.","year":"2012","unstructured":"Zubair M, Malik A, Ahmad J.  Incidence, risk factors for amputation among patients with diabetic foot ulcer in a North Indian tertiary care hospital.","journal-title":"Foot  (Edinb)"},{"key":"ref=34","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00508-014-0630-5","volume":"127","author":"Tabur S.","year":"2015","unstructured":"Tabur S, Eren MA, Celik Y.  The major predictors of amputation and length of stay in diabetic patients with acute foot ulceration.","journal-title":"Wien Klin Wochenschr"},{"key":"ref=35","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.2337\/dc13-0437","volume":"36","author":"Zhao W.","year":"2013","unstructured":"Zhao W, Katzmarzyk PT, Horswell R.  HbA1c and lower-extremity amputation risk in low-income patients with diabetes.","journal-title":"Diabetes Care"},{"key":"ref=36","doi-asserted-by":"crossref","first-page":"635","DOI":"10.2337\/dc10-0878","volume":"34","author":"Callaghan B.C.","year":"2011","unstructured":"Callaghan BC, Feldman E, Liu J.  Triglycerides and amputation risk in patients with diabetes: Ten-year follow up in the distance study.","journal-title":"Diabetes Care"},{"key":"ref=37","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1046\/j.1464-5491.2000.00372.x","volume":"17","author":"Muhlhauser I.","year":"2000","unstructured":"Muhlhauser I, Overmann H, Bender R, Jorgens V, Berger M.  Predictors of mortality and end-stage diabetic complications in patients with type 1 diabetes mellitus on intensified insulin therapy.","journal-title":"Diabet Med"},{"key":"ref=38","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.2337\/diacare.22.7.1029","volume":"22","author":"Adler A.I.","year":"1999","unstructured":"Adler AI, Boyko EJ, Ahroni JH, Smith DG.  Lower-extremity amputation in diabetes. The independent effects of peripheral vascular disease, sensory neuropathy, and foot ulcers.","journal-title":"Diabetes Care"},{"key":"ref=39","doi-asserted-by":"crossref","first-page":"951","DOI":"10.2337\/diacare.22.6.951","volume":"22","author":"Moss S.E.","year":"1999","unstructured":"Moss SE, Klein R, Klein BE.  The 14-year incidence of lower-extremity amputations in a diabetic population. The Wisconsin epidemiologic study of diabetic retinopathy.","journal-title":"Diabetes Care"},{"key":"ref=40","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1080\/14656566.2017.1351946","volume":"18","author":"Katsiki N.","year":"2017","unstructured":"Katsiki N, Purrello F, Tsioufis C, Mikhailidis DP.  Cardiovascular disease prevention strategies for type 2 diabetes mellitus.","journal-title":"Expert Opin Pharmacother"},{"key":"ref=41","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s11883-017-0680-z","volume":"19","author":"Dietrich I.","year":"2017","unstructured":"Dietrich I, Braga G, de Melo F.  The diabetic foot as a proxy for cardiovascular events and mortality review.","journal-title":"Curr Atheroscler Rep"},{"key":"ref=42","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.2337\/dc10-2377","volume":"34","author":"Huang E.S.","year":"2011","unstructured":"Huang ES, Liu JY, Moffet HH, John PM, Karter AJ.  Glycemic control, complications, and death in older diabetic patients: The diabetes and aging study.","journal-title":"Diabetes Care"},{"key":"ref=43","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/bja\/aet381","volume":"111","author":"Sebranek J.J.","year":"2013","unstructured":"Sebranek JJ, Lugli AK, Coursin DB.  Glycaemic control in the perioperative period.","journal-title":"Br J Anaesth"},{"key":"ref=44","first-page":"CD007315","volume":"9","author":"Buchleitner A.M.","year":"2012","unstructured":"Buchleitner AM, Mart\u00ednez-Alonso M, Hern\u00e1ndez M, Sol\u00e0 I, Mauricio D.  Perioperative glycaemic control for diabetic patients undergoing surgery.","journal-title":"Cochrane Database Syst Rev"},{"key":"ref=45","doi-asserted-by":"crossref","first-page":"32","DOI":"10.4103\/0973-3930.43096","volume":"28","author":"Shojaiefard A.","year":"2008","unstructured":"Shojaiefard A, Khorgami Z, Larijani B.  Independent risk factors for amputation in diabetic foot.","journal-title":"Int J Diabetes Dev Ctries"},{"key":"ref=46","doi-asserted-by":"crossref","first-page":"e0188097","DOI":"10.1371\/journal.pone.0188097","volume":"12","author":"Al-Rubeaan K.","year":"2017","unstructured":"Al-Rubeaan K, Almashouq MK, Youssef AM.  All-cause mortality among diabetic foot patients and related risk factors in Saudi Arabia.","journal-title":"PLoS One"},{"key":"ref=47","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.jdiacomp.2014.04.011","volume":"28","author":"Martins-Mendes D.","year":"2014","unstructured":"Martins-Mendes D, Monteiro-Soares M, Boyko EJ.  The independent contribution of diabetic foot ulcer on lower extremity amputation and mortality risk.","journal-title":"J Diabetes Complications"},{"key":"ref=48","first-page":"2098","volume":"377","author":"Rajagopalan S.","year":"2017","unstructured":"Rajagopalan S, Brook R.  Canagliflozin and cardiovascular and renal events in type 2 diabetes.","journal-title":"N Engl J Med"}],"container-title":["Current Vascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/159290","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,11]],"date-time":"2019-08-11T16:04:56Z","timestamp":1565539496000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/159290\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,11]]},"references-count":48,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,6,11]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1570161116666180123112529","relation":{},"ISSN":["1570-1611"],"issn-type":[{"value":"1570-1611","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6,11]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2018-01-01","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-05-14","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-06-14","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-06-11","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}